Chromosomal abnormalities characterize the biological behavior of acute myeloid leukemia
(AML), also facilitating the identification of genes responsible for its development and/or …

In acute myeloid leukemia (AML) close associations are known between cytomorphology
and cytogenetics such as in AML M3/M3v showing at (15; 17) and in AML M4eo associated …

Inv (3)(q21q26)/t (3; 3)(q21; q26) is a feature of a distinctive entity of acute myeloid leukemia
(AML) associated with normal or elevated platelet count, atypical megakaryocytes and …

We report a case of acute myeloid leukemia (AML) M1 showing a 48, XY,+ 13,+ 13
karyotype. Treatment was according to the Medical Research Council AML14 trial protocol …

Three adult de novo acute myeloid leukemias (AML M1, M2, and M4) with an
isochromosome 7p are presented. No additional abnormalities were detected by G‐band …

Acute myelocytic leukemia (AML) is a malignant disease characterized by the proliferation of
immature myelocytic precursor cells causing the disruption of normal bone marrow function …

At the genomic level, acute myeloid leukemia (AML) is characterized by translocations,
inversions and/or deletions involving certain key gene segments, with disruption of the …

Acute myeloid leukemia (AML) cases with monosomy 7 (− 7) and del (7q) comprise a
heterogeneous subgroup. The association of losses in 7q with myeloid leukemia suggests …

Objective: Previously, deletion 6p23 was generally reported in therapy‐related secondary
acute myeloid leukemia (AML) as part of complex karyotypes. In this report, we present two …

Structural abnormalities in the long arm of chromosome 3 have been detected in 7–10% of
patients with acute myelogenous leukemia (AML) or myelodysplastic syndromes. Patients …